The Cardiopulmonary Effects of the Gene-related Peptide Family

Overview

Journal Turk J Pharm Sci

Specialty Pharmacology

Date 2020 Jul 9

PMID 32636714

Citations 2

Authors

Gokcen Telli

Banu Cahide Tel

Bulent Gumusel

Affiliations

Soon will be listed here.

Abstract

Cardiopulmonary diseases are very common among the population. They are high-cost diseases and there are still no definitive treatments. The roles of members of the calcitonin-gene related-peptide (CGRP) family in treating cardiopulmonary diseases have been studied for many years and promising results obtained. Especially in recent years, two important members of the family, adrenomedullin and adrenomedullin2/intermedin, have been considered new treatment targets in cardiopulmonary diseases. In this review, the roles of CGRP family members in cardiopulmonary diseases are investigated based on the studies performed to date.

Citing Articles

It Is Time to Get to Know the Neuroendocrine Cell Hyperplasia of Infancy.

Jin L, Wei W Clin Respir J. 2024; 18(8):e13827.

PMID: 39138819 PMC: 11322232. DOI: 10.1111/crj.13827.

Genetic Delivery and Gene Therapy in Pulmonary Hypertension.

Rai N, Shihan M, Seeger W, Schermuly R, Novoyatleva T Int J Mol Sci. 2021; 22(3).

PMID: 33503992 PMC: 7865388. DOI: 10.3390/ijms22031179.

References

Chen L, Kis B, Hashimoto H, Busija D, Takei Y, Yamashita H . Adrenomedullin 2 protects rat cerebral endothelial cells from oxidative damage in vitro. Brain Res. 2006; 1086(1):42-9. DOI: 10.1016/j.brainres.2006.02.128. View

McLatchie L, Fraser N, Main M, Wise A, Brown J, Thompson N . RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature. 1998; 393(6683):333-9. DOI: 10.1038/30666. View

Pan C, Yang J, Cai D, Zhao J, Gerns H, Yang J . Cardiovascular effects of newly discovered peptide intermedin/adrenomedullin 2. Peptides. 2005; 26(9):1640-6. DOI: 10.1016/j.peptides.2005.02.013. View

Takahashi K, Kikuchi K, Maruyama Y, Urabe T, Nakajima K, Sasano H . Immunocytochemical localization of adrenomedullin 2/intermedin-like immunoreactivity in human hypothalamus, heart and kidney. Peptides. 2005; 27(6):1383-9. DOI: 10.1016/j.peptides.2005.11.004. View

Meens M, Fazzi G, van Zandvoort M, De Mey J . Calcitonin gene-related peptide selectively relaxes contractile responses to endothelin-1 in rat mesenteric resistance arteries. J Pharmacol Exp Ther. 2009; 331(1):87-95. DOI: 10.1124/jpet.109.155143. View

Kandilci H, Gumusel B, Wasserman A, Witriol N, Lippton H . Intermedin/adrenomedullin-2 dilates the rat pulmonary vascular bed: dependence on CGRP receptors and nitric oxide release. Peptides. 2006; 27(6):1390-6. DOI: 10.1016/j.peptides.2005.10.024. View

Bell D, McDermott B . Activity of amylin at CGRP1-preferring receptors coupled to positive contractile response in rat ventricular cardiomyocytes. Regul Pept. 1995; 60(2-3):125-33. DOI: 10.1016/0167-0115(95)00120-4. View

Hirata Y, Takagi Y, Takata S, Fukuda Y, Yoshimi H, Fujita T . Calcitonin gene-related peptide receptor in cultured vascular smooth muscle and endothelial cells. Biochem Biophys Res Commun. 1988; 151(3):1113-21. DOI: 10.1016/s0006-291x(88)80481-9. View

Champion H, Wang R, Santiago J, Murphy W, Coy D, Kadowitz P . Comparison of responses to adrenomedullin and calcitonin gene-related peptide in the feline erection model. J Androl. 1997; 18(5):513-21. View

10.

Grossini E, Molinari C, Mary D, Uberti F, Caimmi P, Vacca G . Intracoronary intermedin 1-47 augments cardiac perfusion and function in anesthetized pigs: role of calcitonin receptors and beta-adrenoreceptor-mediated nitric oxide release. J Appl Physiol (1985). 2009; 107(4):1037-50. DOI: 10.1152/japplphysiol.00569.2009. View

11.

Fujisawa Y, Nagai Y, Miyatake A, Takei Y, Miura K, Shoukouji T . Renal effects of a new member of adrenomedullin family, adrenomedullin2, in rats. Eur J Pharmacol. 2004; 497(1):75-80. DOI: 10.1016/j.ejphar.2004.06.039. View

12.

Copp D . Calcitonin: discovery, development, and clinical application. Clin Invest Med. 1994; 17(3):268-77. View

13.

Telli G, Tel B, Yersal N, Korkusuz P, Gumusel B . Effect of intermedin/adrenomedullin on the pulmonary vascular bed in hypoxia-induced pulmonary hypertensive rats. Life Sci. 2017; 192:62-67. DOI: 10.1016/j.lfs.2017.11.031. View

14.

Keith I, Kraiczi H, Ekman R . Three-week neonatal hypoxia reduces blood CGRP and causes persistent pulmonary hypertension in rats. Am J Physiol Heart Circ Physiol. 2000; 279(4):H1571-8. DOI: 10.1152/ajpheart.2000.279.4.H1571. View

15.

Brain S, Grant A . Vascular actions of calcitonin gene-related peptide and adrenomedullin. Physiol Rev. 2004; 84(3):903-34. DOI: 10.1152/physrev.00037.2003. View

16.

Chang C, Roh J, Hsu S . Intermedin, a novel calcitonin family peptide that exists in teleosts as well as in mammals: a comparison with other calcitonin/intermedin family peptides in vertebrates. Peptides. 2004; 25(10):1633-42. DOI: 10.1016/j.peptides.2004.05.021. View

17.

Vizza C, Letizia C, Sciomer S, Naeije R, Della Rocca G, Di Roma A . Increased plasma levels of adrenomedullin, a vasoactive peptide, in patients with end-stage pulmonary disease. Regul Pept. 2004; 124(1-3):187-93. DOI: 10.1016/j.regpep.2004.07.021. View

18.

Dewachter L, Dewachter C, Naeije R . New therapies for pulmonary arterial hypertension: an update on current bench to bedside translation. Expert Opin Investig Drugs. 2010; 19(4):469-88. DOI: 10.1517/13543781003727099. View

19.

Takei Y, Joss J, Kloas W, Cliff Rankin J . Identification of angiotensin I in several vertebrate species: its structural and functional evolution. Gen Comp Endocrinol. 2004; 135(3):286-92. DOI: 10.1016/j.ygcen.2003.10.011. View

20.

Hirata Y, Hayakawa H, Suzuki Y, Suzuki E, Ikenouchi H, Kohmoto O . Mechanisms of adrenomedullin-induced vasodilation in the rat kidney. Hypertension. 1995; 25(4 Pt 2):790-5. DOI: 10.1161/01.hyp.25.4.790. View